About US
Contact us
-
J&J uses share-the-wisdom approach to spread the word on PrezcobixJohnson & Johnson ($JNJ) is trying a new tack on the old "talk to your doctor" advice. With a new campaign for its HIV drug Prezcobix, the company is urging potential patients to snap a photo and2015/8/25
-
Allergan recalls eye drugs after patients complain of particles, blurred visionSince Allergan ($AGN) andActavisjoined hands to become a new-look Allergan, the company has already had to recall a product from the Actavis side. Now, it's recalling some from the Allergan side, putt2015/8/25
-
Lilly, Sanofi, Novo among many pharma players to throw off big price gains in H1The first half of the year has provided a good ride for Big Pharma and its investors with indices up in the U.S. and Europe. Even Japanese drugmakers avoided the side effects of China's stock market m2015/8/24
-
Ackman's Valeant ties pay off yet again with Sprout buyBill Ackman's relationship with Valeant has paid off big-time since the hedge fund manager first teamed up with the Canadian pharma on its hostile pursuit of Allergan ($AGN). And this time, it's an in2015/8/24
-
Approval system reform for drugs, medical instrumentsChina has decided to reform its appraisal and approval system for drugs and medical instruments with the aim of improving drug safety and quality and encouraging innovation. According to a guideline2015/8/21
-
GSK OTC push marred by super-sized recall of toothpasteThe decision of GlaxoSmithKline ($GSK) CEOAndrew Wittyto double down on consumer health products has not been very popular with some investors, who question the strategy of focusing on low-margin, hig2015/8/21
-
FDA official encourages makers of Low T drugs to work together on a single risks trialWhile data on the heart and stroke risks oftestosteroneenhancers have been mixed, theFDAhas held firm on its position that "Low T" drugs should be used only for medical conditions and not as a lifesty2015/8/21
-
CFDA Vice Minister Wu Zhen meets the delegation of Kenya's National Assembly Departmental Committee on HealthOn the afternoon of August 12, 2015, Wu Zhen, Vice Minister of China Food and Drug Administration (CFDA), met with the delegation of Kenya's National Assembly Departmental Committee on Health headed b2015/8/20
-
Amgen wraps up Aranesp, Enbrel marketing probe with $71M state-level settlementAmgen ($AMGN) is paying up to resolve claims that it broke the rules while marketing anemia drugAranespand anti-inflammatory blockbusterEnbrel. The company has settled with 48 states for $71 million,2015/8/20
-
Horizon puts forth its slate of new Depomed directorsHorizon ($HZNP) has criticized Depomed's ($DEPO) directors for refusing to come to the table, despite its attempts to "engage in good faith" over a combination of the two companies. Now, though, it's2015/8/20